Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Latest News
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer
Publish date:
February 1, 2022
FROM GI CANCERS SYMPOSIUM 2022
A version of this article first appeared on
Medscape.com
.
Pages
« first
1
2
Recommended Reading
GERD: Upper endoscopy may reduce GI cancer mortality
MDedge Hematology and Oncology
Margin marking of polyps before EMR cuts recurrence: Study
MDedge Hematology and Oncology
Abraxane still in short supply for cancer patients
MDedge Hematology and Oncology
Medicare NCDs hinder access to cancer biomarker testing for minorities
MDedge Hematology and Oncology
Oxaliplatin add-on not recommended for elderly with colon cancer
MDedge Hematology and Oncology
Can immunotherapy replace surgery for stomach cancer?
MDedge Hematology and Oncology
Decades of research fail to resolve disparities in gastrointestinal cancer care
MDedge Hematology and Oncology
Endoscopic mucosal resection valuable for cancer diagnosis
MDedge Hematology and Oncology
Novel treatment shows early promise for gastric cancer
MDedge Hematology and Oncology
Potential new standard of care for biliary tract cancer
MDedge Hematology and Oncology
Gastrointestinal Cancer
Head & Neck/Thyroid Cancers
All Specialties
